PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: PQR309|DRUG: Eribulin
Sponsor: PIQUR Therapeutics AG
Collaborators: Hospital Universitario Ramon y Cajal|Hospital Universitari Vall d'Hebron Research Institute|Institut Català d'Oncologia|Churchill Hospital|Barts Cancer Institute|Fundación Instituto Valenciano de Oncología